Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant.
暂无分享,去创建一个
[1] Taskinen,et al. Comparison of three fatty meals in healthy normolipidaemic men: high post‐prandial retinyl ester response to soybean oil , 1998, European journal of clinical investigation.
[2] J. Hokanson,et al. Hypertriglyceridemia as a cardiovascular risk factor. , 1998, The American journal of cardiology.
[3] A. V. van Beek,et al. Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity. , 1998, Journal of lipid research.
[4] M. Taskinen,et al. The Asn‐291→Ser and Ser‐477→Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia , 1997, European journal of clinical investigation.
[5] A. Cooper. Hepatic uptake of chylomicron remnants. , 1997, Journal of lipid research.
[6] J. Boer,et al. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. , 1997, Circulation.
[7] M. Taskinen,et al. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[8] P. Schnohr,et al. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. , 1997, The Journal of clinical investigation.
[9] M. Taskinen,et al. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM , 1997, Diabetologia.
[10] M. Hayden,et al. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. , 1996, The New England journal of medicine.
[11] M. Hayden,et al. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. , 1996, Journal of lipid research.
[12] M. Taskinen,et al. Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. , 1996, Journal of lipid research.
[13] I. Goldberg. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. , 1996, Journal of lipid research.
[14] D. Gaudet,et al. Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[15] M. Hayden,et al. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[16] F. Karpe,et al. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. , 1995, Journal of lipid research.
[17] G. Olivecrona,et al. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. , 1995, Journal of lipid research.
[18] J. Björkegren,et al. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[19] J. Taylor,et al. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Hamsten,et al. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. , 1994, Journal of lipid research.
[21] J Ludbrook,et al. Repeated measurements and multiple comparisons in cardiovascular research. , 1994, Cardiovascular research.
[22] R. Havel,et al. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[23] B. Paulweber,et al. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. , 1993, The Journal of clinical investigation.
[24] S. Humphries,et al. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. , 1992, Atherosclerosis.
[25] J. K. Dunn,et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[26] N. Le,et al. Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia. , 1992, Journal of lipid research.
[27] K. Polonsky,et al. Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. , 1992, The Journal of clinical endocrinology and metabolism.
[28] G. Bengtsson-Olivecrona,et al. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[29] L. Kaplan,et al. Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. , 1991, The Journal of clinical investigation.
[30] A. Takagi,et al. A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes. , 1990, Journal of lipid research.
[31] D G Altman,et al. Analysis of serial measurements in medical research. , 1990, BMJ.
[32] A. Consoli,et al. Mechanism for Underestimation of Isotopically Determined Glucose Disposal , 1989, Diabetes.
[33] J. Ordovás,et al. Postprandial plasma lipoprotein changes in human subjects of different ages. , 1988, Journal of lipid research.
[34] M. Weintraub,et al. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. , 1987, The Journal of clinical investigation.
[35] P. de Knijff,et al. A rapid micromethod for apolipoprotein E phenotyping directly in serum. , 1987, Journal of lipid research.
[36] A. Tall,et al. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. , 1986, The Journal of clinical investigation.
[37] C. Fielding,et al. Effects of postprandial lipemia on plasma cholesterol metabolism. , 1985, The Journal of clinical investigation.
[38] R. Havel,et al. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[40] P. Kinnunen,et al. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.
[41] D. Porte,et al. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. , 1973, The Journal of clinical investigation.
[42] J. Sternberg,et al. A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption , 1968 .
[43] P. Julien,et al. Molecular pathobiology of the human lipoprotein lipase gene. , 1996, Pharmacology & therapeutics.
[44] M. Taskinen,et al. Development and Evaluation of an ELISA Method for the Determination of Lipoprotein Lipase Mass Concentration — Comparison with a Commercial, One-Step Enzyme Immunoassay , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[45] M. Hayden,et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis , 1995, Nature Genetics.
[46] A. Hamsten,et al. Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. , 1995, Journal of lipid research.
[47] D. Arveiler,et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde. , 1995, Journal of lipid research.
[48] A Sajantila,et al. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. , 1993, American journal of human genetics.
[49] G. Watts,et al. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia. , 1993, Journal of lipid research.
[50] D. Gordon,et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.
[51] J. Brunzell. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome , 1989 .
[52] K. Mullis,et al. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. , 1987, Methods in enzymology.
[53] J. Aikens,et al. A microfluorometric method for the determination of free fatty acids in plasma. , 1983, Journal of lipid research.